**Read the new report HERE** Eli Lilly claim: “using all available resources” to fight coronavirus” → Eli Lilly reality: no increase in annual R&D from projections…additional $250M in revenue. Johnson & Johnson claim: “accelerating [its] research & development”  → Johnson & Johnson reality: R&D nearly 10% lower..increasing shareholder dividend by 6.3%  Washington, DC – Today, … Continue reading New Watchdog Report: Big Pharma R&D Rhetoric vs. Reality